It is known that IDH-mutant gliomas have fewer tumor-infiltrating immune cells, including T cells, microglia, and macrophages, compared to IDH wild-type tumors; thus IDH-mutant tumors typically exemplify “cold tumors” and may not respond to immunotherapies. This evidence concerns the gene IDH1 and neoplasm.